Specialties 2009 P
-
06/09/2009 -- First FDA 510(k) approval for home-use wrinkle-treatment device goes to Palomar
JUNE 9, 2009--Palomar Medical Technologies (Burlington, MA) has become the first company to win a 510k over-the-counter (OTC) clearance from the U.S. Food and Drug Administration (FDA) for a new, patented, home use laser skin treatment device for the reduction of periorbital wrinkles (a.k.a. eye wrinkles or crow's feet). The FDA clearance allows the cosmetic laser device to be marketed and sold directly to consumers without a prescription. -
06/11/2009 -- FDA approves Carl Zeiss Meditec's new optical coherence tomography software
JUNE 11, 2009--Carl Zeiss Meditec (Dublin, CA) says the U.S. Food and Drug Administration (FDA) has granted clearance for commercial distribution of the company's new suite of optical coherence tomography (OCT) software. The software supports Zeiss's Cirrus HD-OCT system; Cirrus HD-OCT 4.0 enables in vivo viewing, axial cross-sectional, and three-dimensional imaging and measurement of anterior and posterior ocular structures. -
06/12/2009 -- Breast cancer imaging system developer ratchets up business development efforts
JUNE 12, 2009--Imaging Diagnostic Systems, Inc., (Plantation, FL), maker of laser optical imaging systems for breast cancer detection, says it has retained the services of a senior business management consultant to accelerate and focus the company's business development efforts. Goals are to prepare and execute a US and European business development plan, launch new technology initiatives in laser fluorescence imaging, and complete Pre-Market Approval (PMA) submission to the FDA. -
06/16/2009 -- Quantum dots enable discovery of breakthrough AMD biomarker
JUNE 16, 2009--Researchers have discovered a biomarker for age-related macular degeneration (AMD). Called CCR3, the marker shows strong potential for both early detection and preventive treatment of the disease. They made the discovery using quantum dots--attached to anti-CCR3 antibodies--which bind to CCR3 on abnormal blood vessels in the eyes of living mice. This makes the vessels visible through conventional means before they have penetrated the retina. -
06/17/2009 -- Bright, stable nanocrystals enable views of intra-cellular activity
BERKELEY, CA, USA--Bright, stable and bio-friendly single-molecule light-emitting nanocrystals, developed at the U.S. Department of Energy's (DOE) Lawrence Berkeley National Laboratory (LBNL), can act as individual investigators of in-vivo intra-cellular activity. The probes represent a significant step in understanding the behaviors of proteins and other components in complex systems such as a living cell.
POST A COMMENT
BioOptics World Magazine
Most Popular Article
Ophthalmology
Recent Articles
BioOptics Blogs
Intrinsic fluorescence of the parathyroid gland reduces risk of endocrine surgery
03/26/2013 - BioOptics StudentView Blog
BioOptics World Products
Topic Index
BioOptics World Archives
